<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Medical and Human Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/63594C94-817B-4096-AA4F-68DEF0136CC8"><gtr:id>63594C94-817B-4096-AA4F-68DEF0136CC8</gtr:id><gtr:firstName>Stavros</gtr:firstName><gtr:otherNames>Michael</gtr:otherNames><gtr:surname>Stivaros</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600485"><gtr:id>70573A6B-03FF-4701-BDDB-9DC8A346C442</gtr:id><gtr:title>Language Based Decision Support System For Treatment Planning In Patients With Sub-arachnoid Haemorrhage.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0600485</gtr:grantReference><gtr:abstractText>Sub-arachnoid haemorrhage (or bleeding over the surface of the brain,) is a debilitating disease that strikes suddenly and without warning. Until recently the prospects for sufferers of this illness were very bleak, with death in almost half and severe disability in most survivors. The United Kingdom has pioneered advanced treatments for this disease including new keyhole-surgery techniques which offer much greater survival and greatly reduced disability. However these new techniques are very complex and are being developed at such a fast rate, that the clinicians looking after the patients are often unsure as to which exact form of treatment to offer. In addition it is often very difficult to give patients and their relatives exact information on their chances of survival as well as the type and risks of the disabilities they may suffer. This project will design a computer system that analyses data about individual patients and their scans, using this information to guide the doctor through the decision making process. It will update itself taking into account new research as it becomes available and keep track of how each individual patient has done. In this way it will become a world reference point for doctors treating sub-arachnoid haemorrhage, giving up to the minute accurate treatment advice tailored for individual patients and offering real-time prognosis information. This system will keep the United Kingdom at the forefront in the treatment of this often catastrophic illness.</gtr:abstractText><gtr:technicalSummary>Aims: Develop and evaluate the core components of a language-based decision support system (DSS) for therapeutic planning in patients with aneurysmal sub-arachnoid haemorrhage (SAH). Objectives: Produce a descriptive language model forming the basis of a Bayesian DSS to guide treatment decisions, specifically: 1) compile a list of descriptive features which have shown prognostic implications for outcome; 2) assess feature inter and intra-observer reproducibility; 3) examine computer-based guides for improving baseline reproducibility; 4) identify the prognostic value of individual features for a range of clinical outcomes; 5) develop a web based reporting system using a Bayesian DSS algorithm and simple language model, enabling prognostic classification of new cases in real-time. Design: Prospective studies such as the International Sub-arachnoid Aneurysm Trial (ISAT) have confirmed the benefits of endovascular versus surgical treatment however there is remarkably little data to guide therapeutic decisions. Some imaging features are predominant in treatment planning whereas others have a lack of objective evidence. Imaging data will be used to generate probabilities against a series of clinical outcomes allowing predictions to be derived using Bayes theory. The proposed method based on Bayesian DSS is an important study on how to combine expert knowledge with machine learning (learning the posterior probabilities based on Bayesian rules), which is an important and fundamental issue in knowledge discovery and decision support. Methodology: Imaging feature descriptive terms will be identified from a review of world literature. The ability of neuroradiologists to identify these features will be assessed to determine which features suffer from inter and intra observer error. The features which can be reproduced will be compared to known patient outcomes to determine their initial prognostic values. A DSS framework and language model will then be implemented allowing predictive outcome probabilities to be determined using Bayes theory. Validation will then be performed using 100 patients from the original ISAT trial not used previously in the project. Scientific and medical opportunities: The project will generate extensive evidence concerning the independent value of predictive features in SAH, and provide a substantial feasibility study of a DSS to support ongoing multicentre studies of SAH therapy. It represents the core of a system which could be improved by expansion of outcome indicators, determinant features and integration of improved techniques for feature identification such as formalised ontologies, natural language models or automated image analysis.</gtr:technicalSummary><gtr:fund><gtr:end>2009-09-03</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-09-04</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>192024</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Child and Adolescent Psychiatry</gtr:department><gtr:description>SANTA</gtr:description><gtr:id>C77217CD-4B2D-4C05-8D73-7559451B15C1</gtr:id><gtr:impact>PhD Studentship</gtr:impact><gtr:outcomeId>SCrGU62FPVd-1</gtr:outcomeId><gtr:partnerContribution>Clinical assessment of children with autism and provision of placebo and liquid formulation drug intervention</gtr:partnerContribution><gtr:piContribution>Application of imaging biomarker investigation in children with Autism as part of a therapeutic intervention.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>RCR public engagement</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>63308B83-6ED2-4BBE-B117-9E07D7EB8D95</gtr:id><gtr:impact>Talk sparked local debate at lecture then European debate following reporting in Aunt Minnie Europe

Was approached by two medical student about a career in Academic Neuroradiology, and three school student about careers in radiology.</gtr:impact><gtr:outcomeId>5464768f71d4d0.91619844</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.auntminnieeurope.com/index.aspx?sec=log&amp;URL=http%3a%2f%2fwww.auntminnieeurope.com%2findex.aspx%3fsec%3dsup%26sub%3dcto%26pag%3ddis%26ItemID%3d610688</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Brain and Spinal Injuries Charity Engagement</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F4C0BF86-E113-4FB0-912A-E41764526C03</gtr:id><gtr:impact>Discussed the decision support system and what it offers to both patients as well as to health professionals. BASIC is a charitable organisation that supports patients and famillies of those suffering from subarachnoid haemorrage. The primary meeting was with the Director of the charity and discussion with several fundraisers from the charity

BASIC have agreed to a yearly patient/familly review of the system and to interact with regards to further development of the system in the future. This will enable identification of issues specific to patient needs regarding subarachnoid haemorrhage.</gtr:impact><gtr:outcomeId>E507BBD6951</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010,2011,2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>293694</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EU CORDIS FP7</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>288328</gtr:fundingRef><gtr:id>064B5DBA-47B9-4103-AE7F-2A06EE00C433</gtr:id><gtr:outcomeId>StkhYVRa2Hk</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>99797</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Manchester Academic Health Science Centre</gtr:department><gtr:description>Manchester Academic Health Sciences Centre</gtr:description><gtr:end>2016-05-02</gtr:end><gtr:fundingOrg>University of Manchester</gtr:fundingOrg><gtr:id>FF17E615-7409-4BBC-B8A8-C41AB802C048</gtr:id><gtr:outcomeId>U9Q22V8r1Xb</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK cancer imaging centre co-I 2% split</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>8C3B430F-FB96-4DEB-A0E5-61E01E077EC9</gtr:id><gtr:outcomeId>56e0524c3cd862.41032419</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Confidence in Concept</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>0E758A39-8A44-4BA5-99C4-5FF8F0E755DB</gtr:id><gtr:outcomeId>Mn1e3j9zdph</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>982683</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Clinician Scientist Award</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>NIHR/CS/010/021</gtr:fundingRef><gtr:id>59DD22AD-A4CC-4A13-8FD5-FEE31CD3061E</gtr:id><gtr:outcomeId>bMVoSRQ9jD2</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A database containing over 300 publications encompasing 10,000 cerebral aneurysms. This has used a novel language modeling technique for assimilation of this data.</gtr:description><gtr:id>ABE8B4B8-A29E-41C1-B27C-2C2EEB7F9DAB</gtr:id><gtr:impact>We have now developed a novel generic methodology for data assimilation and search which can be applied in any health science domain. This is now undergoing IP protection prior to publication.</gtr:impact><gtr:outcomeId>B6B9CD53303</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Subarachnoid Haemorrhage Knowledgebase</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>4CDDC32E-1E08-4240-B0AB-54E2B72D573E</gtr:id><gtr:title>Acute disseminated encephalomyelitis in conjunction with inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/706056a50c16d46957664ebb8e27c451"><gtr:id>706056a50c16d46957664ebb8e27c451</gtr:id><gtr:otherNames>Aziz M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1090-3798</gtr:issn><gtr:outcomeId>pm_15404_24_23199676</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7C3D279-25BC-4ACF-88FD-B84248CA1ACB</gtr:id><gtr:title>Does black blood MRA have a role in the assessment of intracerebral aneurysms?</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61478e657b41ce79fdc03379bcaa4059"><gtr:id>61478e657b41ce79fdc03379bcaa4059</gtr:id><gtr:otherNames>Stivaros SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn><gtr:outcomeId>BEB6486FA1B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB8009A4-451E-479D-B480-831F6F44028E</gtr:id><gtr:title>Endoscopic third ventriculostomy: predicting outcome with phase-contrast MR imaging.</gtr:title><gtr:parentPublicationTitle>Radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61478e657b41ce79fdc03379bcaa4059"><gtr:id>61478e657b41ce79fdc03379bcaa4059</gtr:id><gtr:otherNames>Stivaros SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0033-8419</gtr:issn><gtr:outcomeId>1437B5EA671</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65EC8D28-541A-4A43-99D5-5BE77F2BE6B3</gtr:id><gtr:title>Leukoencephalopathy with calcifications and cysts: a purely neurological disorder distinct from coats plus.</gtr:title><gtr:parentPublicationTitle>Neuropediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/442a8d318d127d0d8a728c45f2521737"><gtr:id>442a8d318d127d0d8a728c45f2521737</gtr:id><gtr:otherNames>Livingston JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0174-304X</gtr:issn><gtr:outcomeId>5464755b102198.45915131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48A58266-176E-4F6E-97AB-3D5DF0C11FA3</gtr:id><gtr:title>Recognizable phenotypes associated with intracranial calcification.</gtr:title><gtr:parentPublicationTitle>Developmental medicine and child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/442a8d318d127d0d8a728c45f2521737"><gtr:id>442a8d318d127d0d8a728c45f2521737</gtr:id><gtr:otherNames>Livingston JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-1622</gtr:issn><gtr:outcomeId>pm_15404_24_23121296</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D06CECF-0B1E-4476-9F25-8DE6444E7F76</gtr:id><gtr:title>How the imaging investigation of EAST syndrome points towards the future of radiological multi-parametric phenotyping of a genetic disease.</gtr:title><gtr:parentPublicationTitle>Developmental medicine and child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99885f08d4fb2c53e9f57d8e1d941f3f"><gtr:id>99885f08d4fb2c53e9f57d8e1d941f3f</gtr:id><gtr:otherNames>Stivaros S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-1622</gtr:issn><gtr:outcomeId>pm_15404_24_23924081</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DF60890-2199-47D4-8E9C-C82402A2EA75</gtr:id><gtr:title>Changing concepts of cerebrospinal fluid hydrodynamics: role of phase-contrast magnetic resonance imaging and implications for cerebral microvascular disease.</gtr:title><gtr:parentPublicationTitle>Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61478e657b41ce79fdc03379bcaa4059"><gtr:id>61478e657b41ce79fdc03379bcaa4059</gtr:id><gtr:otherNames>Stivaros SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1878-7479</gtr:issn><gtr:outcomeId>AF7C71FF1BB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47E1FE89-2FCE-46FE-A2CB-79E47B7A682F</gtr:id><gtr:title>Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patients.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c62584b1a3d0d6b1d4604a164e127a4"><gtr:id>7c62584b1a3d0d6b1d4604a164e127a4</gtr:id><gtr:otherNames>Hexter A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>58c97372d5c6c4.10527729</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C7BD4FA-584E-4128-84F4-6E9C2E8D8361</gtr:id><gtr:title>Intracranial calcification in childhood: a review of aetiologies and recognizable phenotypes.</gtr:title><gtr:parentPublicationTitle>Developmental medicine and child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/442a8d318d127d0d8a728c45f2521737"><gtr:id>442a8d318d127d0d8a728c45f2521737</gtr:id><gtr:otherNames>Livingston JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0012-1622</gtr:issn><gtr:outcomeId>5464755ad4a6d9.57043213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAABCB26-9A5D-4FA9-A42C-C287A8D1B1DE</gtr:id><gtr:title>Pediatric intracranial clear cell meningioma associated with a germline mutation of SMARCE1: a novel case.</gtr:title><gtr:parentPublicationTitle>Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b83e51aa60e57d3f6adb668b65c899ab"><gtr:id>b83e51aa60e57d3f6adb668b65c899ab</gtr:id><gtr:otherNames>Raffalli-Ebezant H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0256-7040</gtr:issn><gtr:outcomeId>5464755b8908b5.31136436</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DE708F0-FE72-4DBC-B5EF-20E60B4C1852</gtr:id><gtr:title>Ventricular metastatic dissemination of a paediatric craniopharyngioma: case report and literature review.</gtr:title><gtr:parentPublicationTitle>British journal of neurosurgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/687eb816e7dad91ea91108a346c0ad9c"><gtr:id>687eb816e7dad91ea91108a346c0ad9c</gtr:id><gtr:otherNames>Carleton-Bland N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0268-8697</gtr:issn><gtr:outcomeId>58c97278e98ac8.75869242</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD917F93-4408-4BF7-BD99-494660304496</gtr:id><gtr:title>Imaging of brain tumors: perfusion/permeability.</gtr:title><gtr:parentPublicationTitle>Neuroimaging clinics of North America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6785ec19059aefa9f81c03cac6def892"><gtr:id>6785ec19059aefa9f81c03cac6def892</gtr:id><gtr:otherNames>Thompson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1052-5149</gtr:issn><gtr:outcomeId>VNRLcK8nPqs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B877E6BB-F069-480B-A562-42A834AF0FF9</gtr:id><gtr:title>Quantification of structural changes in the corpus callosumin children with profound hypoxic-ischaemic brain injury.</gtr:title><gtr:parentPublicationTitle>Pediatric radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61478e657b41ce79fdc03379bcaa4059"><gtr:id>61478e657b41ce79fdc03379bcaa4059</gtr:id><gtr:otherNames>Stivaros SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0301-0449</gtr:issn><gtr:outcomeId>56e050df331a70.26751171</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CC73E0E-2991-4259-9B6E-A111BCA877E6</gtr:id><gtr:title>Decision support systems for clinical radiological practice -- towards the next generation.</gtr:title><gtr:parentPublicationTitle>The British journal of radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61478e657b41ce79fdc03379bcaa4059"><gtr:id>61478e657b41ce79fdc03379bcaa4059</gtr:id><gtr:otherNames>Stivaros SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0007-1285</gtr:issn><gtr:outcomeId>csBeubQP2Rz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B74C98AB-518E-40D5-A74D-9AB0A1670472</gtr:id><gtr:title>Randomised controlled trial of simvastatin treatment for autism in young children with neurofibromatosis type 1 (SANTA).</gtr:title><gtr:parentPublicationTitle>Molecular autism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99885f08d4fb2c53e9f57d8e1d941f3f"><gtr:id>99885f08d4fb2c53e9f57d8e1d941f3f</gtr:id><gtr:otherNames>Stivaros S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5aaa8508205701.08291417</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>444082A3-0997-4839-A37A-AB82FF6DBFF4</gtr:id><gtr:title>Pollicization of the index finger in Fanconi anaemia: appearances and functionality 40&amp;nbsp;years after the intervention.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61478e657b41ce79fdc03379bcaa4059"><gtr:id>61478e657b41ce79fdc03379bcaa4059</gtr:id><gtr:otherNames>Stivaros SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>5464755b651883.09428354</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B03DF646-9BC7-4954-B173-95E13F8F146B</gtr:id><gtr:title>The management of cochlear nerve deficiency.</gtr:title><gtr:parentPublicationTitle>Cochlear implants international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da0f444e8c1125e3deac2be69bddcc7e"><gtr:id>da0f444e8c1125e3deac2be69bddcc7e</gtr:id><gtr:otherNames>Freeman SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1467-0100</gtr:issn><gtr:outcomeId>5464755b3e40e0.79784497</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600485</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>A77DAE3A-499B-4F46-971D-6C82F51F9C2E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Stroke</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>B7F5A9CA-62C7-4E68-A2B2-3D6CCA85E16B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>7.3  Management and decision making</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>